• Reported GAAP EPS of -$0.05 up 28.57% YoY • Reported revenue of $1.11M up 182.28% YoY
Bullish
Dyadic's revenue grew 182.3% to $1,110,956, driven by strategic shifts to commercialization, new partnerships, and product launches like AlbuFree DX and DNase I.
Bearish
Dyadic faces substantial doubt about its ability to continue as a going concern, is non-compliant with Nasdaq listing standards, and has high customer and CRO concentration risks.